586 related articles for article (PubMed ID: 9672419)
1. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
Naef R; Suter U
Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
[TBL] [Abstract][Full Text] [Related]
2. Regulation of myelin-specific gene expression. Relevance to CMT1.
Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
[TBL] [Abstract][Full Text] [Related]
3. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice.
Adlkofer K; Martini R; Aguzzi A; Zielasek J; Toyka KV; Suter U
Nat Genet; 1995 Nov; 11(3):274-80. PubMed ID: 7581450
[TBL] [Abstract][Full Text] [Related]
4. New vistas on the pathomechanism of Charcot-Marie-Tooth and related peripheral neuropathies.
Müller HW
Ann N Y Acad Sci; 1999 Sep; 883():152-9. PubMed ID: 10586241
[TBL] [Abstract][Full Text] [Related]
5. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves.
Maier M; Berger P; Nave KA; Suter U
Mol Cell Neurosci; 2002 May; 20(1):93-109. PubMed ID: 12056842
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies.
Nelis E; Haites N; Van Broeckhoven C
Hum Mutat; 1999; 13(1):11-28. PubMed ID: 9888385
[TBL] [Abstract][Full Text] [Related]
7. Peripheral myelin protein 22: facts and hypotheses.
Suter U; Snipes GJ
J Neurosci Res; 1995 Feb; 40(2):145-51. PubMed ID: 7745607
[TBL] [Abstract][Full Text] [Related]
8. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation.
Giambonini-Brugnoli G; Buchstaller J; Sommer L; Suter U; Mantei N
Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691
[TBL] [Abstract][Full Text] [Related]
9. Genetic basis of inherited peripheral neuropathies.
Suter U; Patel PI
Hum Mutat; 1994; 3(2):95-102. PubMed ID: 7515304
[TBL] [Abstract][Full Text] [Related]
10. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies.
Naef R; Suter U
Neurobiol Dis; 1999 Feb; 6(1):1-14. PubMed ID: 10078969
[TBL] [Abstract][Full Text] [Related]
11. Widespread expression of the peripheral myelin protein-22 gene (PMP22) in neural and non-neural tissues during murine development.
Baechner D; Liehr T; Hameister H; Altenberger H; Grehl H; Suter U; Rautenstrauss B
J Neurosci Res; 1995 Dec; 42(6):733-41. PubMed ID: 8847735
[TBL] [Abstract][Full Text] [Related]
12. [Molecular pathology of Charcot-Marie-Tooth disease type 1A: abnormal expression of PMP-22].
Yoshikawa H; Nishimura T; Yanagihara T
Rinsho Shinkeigaku; 1995 Dec; 35(12):1441-3. PubMed ID: 8752424
[TBL] [Abstract][Full Text] [Related]
13. Transgenic mouse models of CMT1A and HNPP.
Suter U; Nave KA
Ann N Y Acad Sci; 1999 Sep; 883():247-53. PubMed ID: 10586249
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of PMP22 in Slovak patients with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies.
Resko P; Radvansky J; Odnogova Z; Baldovic M; Minarik G; Polakova H; Palffy R; Kadasi L
Gen Physiol Biophys; 2011 Dec; 30(4):379-88. PubMed ID: 22131320
[TBL] [Abstract][Full Text] [Related]
15. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of hereditary neuropathies.
Chance PF
Phys Med Rehabil Clin N Am; 2001 May; 12(2):277-91. PubMed ID: 11345007
[TBL] [Abstract][Full Text] [Related]
17. The peripheral myelin protein 22 and epithelial membrane protein family.
Jetten AM; Suter U
Prog Nucleic Acid Res Mol Biol; 2000; 64():97-129. PubMed ID: 10697408
[TBL] [Abstract][Full Text] [Related]
18. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L
J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural distribution of PMP22 in Charcot-Marie-Tooth disease type 1A.
Haney C; Snipes GJ; Shooter EM; Suter U; Garcia C; Griffin JW; Trapp BD
J Neuropathol Exp Neurol; 1996 Mar; 55(3):290-9. PubMed ID: 8786387
[TBL] [Abstract][Full Text] [Related]
20. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
